US$ 26.02
glp-1 receptor agonist and dpp-4 inhibitor combination not recommended The Role of Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect GLP-1 receptor agonist versus DPP-4
Description
Clinical relevance of antiexenatide antibodies: safety, efficacy and crossreactivity with longterm treatment

doi: 10.1111/dom.13160

doi: 10.1172/JCI81335 [DOI] [PMC free article] [PubMed] [Google Scholar] 35.Shi X, Chacko S, Li F, et al

J Clin Endocrinol Metab 99(7):24772485
When were sick with an illness our body plays a delicate orchestra to balance producing enough of an immune and inflammatory response to deal with the illness, while also producing enough of an anti-inflammatory effect to not allow our immune system to damage our body
